AANP PMHNP Certification Practice Exam V1 2026/2027 | PMHNP Certification Exam Prep, Practice Questions & Answers | Psychiatric Mental Health NP Review

AANP PMHNP Certification Practice Exam
V1 2026/2027 | PMHNP Certification Exam
Prep, Practice Questions & Answers |
Psychiatric Mental Health NP Review

AANP PMHNP CERTIFICATION PRACTICE EXAM V1 2026/2027

DOCUMENT OVERVIEW:

• This comprehensive practice exam contains verified multiple-choice questions
designed to simulate the actual PMHNP certification examination, covering all
major content domains including assessment, pharmacology, therapeutics, and
special populations.

• Use this material by studying questions grouped by topic, reviewing each rationale
thoroughly, and taking full-length practice tests to build time management skills
and identify knowledge gaps before your certification attempt.

===============================================================

QUESTION 1

A 34-year-old male presents with a 6-month history of persistent depressed
mood, anhedonia, sleep disturbance, and decreased concentration. He denies
suicidal ideation. What is the minimum duration of symptoms required to
diagnose Major Depressive Disorder?

A) Two weeks

B) Three weeks

C) Four weeks

D) Two months

E) Six months

CORRECT ANSWER: D) Two months

Rationale: Major Depressive Disorder requires a minimum of two weeks of
depressed mood or loss of interest/pleasure (anhedonia) plus at least five total
depressive symptoms that cause significant distress or functional impairment. The

,five symptoms must include depressed mood or anhedonia plus additional
symptoms from the DSM-5 criteria. A two-week minimum distinguishes MDD from
adjustment disorders, but when we add the requirement that anhedonia must also
be present with multiple other symptoms, the duration typically reflects ongoing
episodes meeting full criteria, which is two weeks minimum, though this case
describes six months of symptoms meeting full diagnostic criteria.



QUESTION 2

A 28-year-old woman is started on sertraline for anxiety. After two weeks, she
reports increased anxiety and restlessness. What is the most appropriate
initial intervention?

A) Discontinue sertraline immediately

B) Reassure her that this is a common initial response and continue the medication

C) Add benzodiazepines to manage the worsening anxiety

D) Reduce the dose of sertraline

E) Switch to a different SSRI

CORRECT ANSWER: B) Reassure her that this is a common initial response
and continue the medication

Rationale: Initial anxiety activation is a recognized side effect that occurs in the first
1-2 weeks of SSRI therapy in approximately 10-15% of patients. This symptom
typically resolves within 2-4 weeks as the body adjusts. Continuing the medication
with patient reassurance and education is the evidence-based approach.
Immediate discontinuation risks relapse and withdrawal symptoms. Adding
benzodiazepines may be considered if symptoms are severe, but it's not the first
intervention for expected transient activation.



QUESTION 3

,Which of the following neurotransmitter systems is primarily implicated in
the pathophysiology of Major Depressive Disorder?

A) Acetylcholine and dopamine

B) Serotonin, norepinephrine, and dopamine

C) GABA and glutamate

D) Histamine and acetylcholine

E) Serotonin and acetylcholine

CORRECT ANSWER: B) Serotonin, norepinephrine, and dopamine

Rationale: The monoamine hypothesis of depression involves dysregulation of
serotonin, norepinephrine, and dopamine. This is the theoretical basis for most
antidepressant medications. SSRIs increase serotonin, SNRIs increase serotonin
and norepinephrine, and bupropion increases dopamine and norepinephrine.
While GABA and glutamate play roles in anxiety and mood regulation, they are not
considered primary in MDD pathophysiology.



QUESTION 4

A 45-year-old male with bipolar I disorder is hospitalized for acute mania.
Which medication would be the most appropriate first-line choice for acute
mania?

A) Fluoxetine

B) Lithium or an atypical antipsychotic

C) Benzodiazepines alone

D) Buspirone

E) Gabapentin

CORRECT ANSWER: B) Lithium or an atypical antipsychotic

Rationale: First-line treatment for acute mania includes lithium or atypical
antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone). These

, medications have the strongest evidence base and fastest onset of action in acute
mania. Fluoxetine can precipitate or worsen mania in bipolar disorder.
Benzodiazepines are used adjunctively for agitation and sleep but not as
monotherapy. Buspiron and gabapentin lack evidence for acute mania treatment.



QUESTION 5

A 32-year-old woman with Generalized Anxiety Disorder is interested in non-
pharmacological treatment. Which psychotherapeutic approach has the
strongest evidence base for GAD?

A) Psychoanalytic psychotherapy

B) Cognitive-Behavioral Therapy (CBT)

C) Supportive therapy

D) Gestalt therapy

E) Hypnotherapy

CORRECT ANSWER: B) Cognitive-Behavioral Therapy (CBT)

Rationale: CBT has the most robust empirical support for treating GAD. It addresses
maladaptive thought patterns, worry cycles, and behavioral avoidance through
structured techniques. Multiple randomized controlled trials demonstrate efficacy
comparable to or exceeding pharmacotherapy. While other therapies may be
helpful, CBT is considered first-line psychotherapy for GAD per evidence-based
guidelines.



QUESTION 6

A 19-year-old male presents with sudden onset of auditory hallucinations,
paranoid delusions, disorganized speech, and bizarre behavior over the past
three weeks. He has no significant medical history and denies substance use.
What is the most likely diagnosis?

A) Brief Psychotic Disorder